vaccine delivery markets for microneedle devices   Published February 2017  •  Catalog no. FVDM899F17  •  Price US $3,850


Vaccines are recognized as one of the most significant healthcare developments in the last one hundred years. In spite of their role in improving quality-of-life and drastically reducing the level of morbidity and mortality from infectious diseases, the ability of healthcare and state institutions to maximize access to many millions of underserved people has still not been realized. This is a complex picture that is characterized by significant regional and socioeconomic factors. One major obstacle is cost, particularly for many underdeveloped countries. Microneedle technology, which has been successfully used to delivery therapeutic drugs, continues to be investigated as a vaccine delivery method. The relative simplicity and safety of microneedles makes them well-suited for use in mass immunization as well as for single patients. Numerous companies are currently involved in clinical development to identify the true potential of this technology.

 

Bar_Graph  Vaccine Delivery Markets for Microneedle Devices – Report Brochure (Download PDF)

Blue document  Vaccine Delivery Markets for Microneedle Devices – Report Order Form (Download PDF)


What You Will Learn

• What prophylactic vaccines are currently approved or in development for administration via microneedle devices?
• What are the key public health factors associated with addressing the unmet need for vaccination?
• What are the key factors that are influencing demand for vaccine delivery via microneedles ?
• How important are drug developer-device manufacturer relationships and what are the key alliances in the industry?
• What are the essential design factors, material selection issues, technologies and market development issues for microneedle devices that deliver vaccines?
• What is the addressable market for vaccines that are supplied for microneedle delivery?
• What are the significant regional economic and regulatory factors that will influence efforts to commercialize microneedle-administered vaccines?


Vaccine Delivery Markets for Microneedle Devices – Summary of Contents

Executive Summary

The Vaccine Administration Market Opportunity
Global Vaccine Demographics
Regional Factors in Infectious Disease
Public Awareness & Education
Personal Hygiene and Local Cultures
Access to Healthcare
Vaccination and Public Health Factors
Healthcare Infrastructure
Storage and Shelf Life
Immunogenicity
Dosing Frequency
Patient Attitudes and Misconceptions
Patient/Caregiver Safety & Device Disposal

Intradermal/Transcutaneous Dosing Drivers & Enablers
Morbidity & Mortality
Vaccine Dose Sparing
NGO Funding Programs
Government Technology Transfer Programs

Microneedle Devices – Design & Technology
Microneedle Types
Microneedle Product Categories
Syringe-mounted Microneedles
Single Needles
Multiple Needles
Patch and Stamp Type Arrays
Microneedle Manufacturing
Material Selection Issues
Fabrication Techniques

The Current Landscape
Approved Products
Product Development
Vaccines
Devices
Combination Products
Clinical Development by Country/Region

The Market Picture to 2022
Addressable Markets
Therapeutic
Acute Infection
Chronic Infection
Seasonal Infection
Geographic
Developed Economies
Emerging Regions
Underdeveloped Regions
Public/Private Programs & Initiatives
Vaccine Supplier/Device Developer Collaborations

Vaccine Delivery Markets – Market Factors
Evolving Disease Targets
New/Reformulated Vaccines
Regulatory Issues
The Critical Role of NGOs
Managed Care
Clinical Trial Factors

Company Profiles